92 related articles for article (PubMed ID: 25048142)
1. Structure-based clustering of major histocompatibility complex (MHC) proteins for broad-based T-cell vaccine design.
Tong JC; Tan TW; Ranganathan S
Methods Mol Biol; 2014; 1184():503-11. PubMed ID: 25048142
[TBL] [Abstract][Full Text] [Related]
2. Definition of MHC supertypes through clustering of MHC peptide-binding repertoires.
Reche PA; Reinherz EL
Methods Mol Biol; 2007; 409():163-73. PubMed ID: 18449999
[TBL] [Abstract][Full Text] [Related]
3. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
4. Prediction of peptide-MHC binding using profiles.
Reche PA; Reinherz EL
Methods Mol Biol; 2007; 409():185-200. PubMed ID: 18450001
[TBL] [Abstract][Full Text] [Related]
5. Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design.
Halling-Brown M; Shaban R; Frampton D; Sansom CE; Davies M; Flower D; Duffield M; Titball RW; Brusic V; Moss DS
Mol Immunol; 2009 Aug; 46(13):2699-705. PubMed ID: 19560824
[TBL] [Abstract][Full Text] [Related]
6. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
7. New tools, new approaches and new ideas for vaccine development.
De Groot AS; Moise L
Expert Rev Vaccines; 2007 Apr; 6(2):125-7. PubMed ID: 17408360
[No Abstract] [Full Text] [Related]
8. EpiToolKit--a web-based workbench for vaccine design.
Schubert B; Brachvogel HP; Jürges C; Kohlbacher O
Bioinformatics; 2015 Jul; 31(13):2211-3. PubMed ID: 25712691
[TBL] [Abstract][Full Text] [Related]
9. Characterizing T-cell epitopes in vaccine candidates.
Pink JR; Sinigaglia F
Immunol Today; 1989 Dec; 10(12):408-9. PubMed ID: 2482742
[TBL] [Abstract][Full Text] [Related]
10. Static energy analysis of MHC class I and class II peptide-binding affinity.
Davies MN; Flower DR
Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
[TBL] [Abstract][Full Text] [Related]
11. A structure-based approach for prediction of MHC-binding peptides.
Altuvia Y; Margalit H
Methods; 2004 Dec; 34(4):454-9. PubMed ID: 15542371
[TBL] [Abstract][Full Text] [Related]
12. Implementing the modular MHC model for predicting peptide binding.
DeLuca DS; Blasczyk R
Methods Mol Biol; 2007; 409():261-71. PubMed ID: 18450006
[TBL] [Abstract][Full Text] [Related]
13. Immunoinformatics and the prediction of immunogenicity.
Flower DR; Doytchinova IA
Appl Bioinformatics; 2002; 1(4):167-76. PubMed ID: 15130835
[TBL] [Abstract][Full Text] [Related]
14. MHC: function and implication on vaccine development.
Eckels DD
Vox Sang; 2000; 78 Suppl 2():265-7. PubMed ID: 10938966
[TBL] [Abstract][Full Text] [Related]
15. Predicting peptide binding to Major Histocompatibility Complex molecules.
Liao WW; Arthur JW
Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
[TBL] [Abstract][Full Text] [Related]
16. Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.
Madurga S; Belda I; Llorà X; Giralt E
Protein Sci; 2005 Aug; 14(8):2069-79. PubMed ID: 16046628
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.
Berzofsky JA
J Clin Invest; 1988 Dec; 82(6):1811-7. PubMed ID: 2974044
[No Abstract] [Full Text] [Related]
18. Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.
Almagro JC; Vargas-Madrazo E; Lara-Ochoa F; Horjales E
Protein Sci; 1995 Sep; 4(9):1708-17. PubMed ID: 8528069
[TBL] [Abstract][Full Text] [Related]
19. Antigen processing: a critical factor in rational vaccine design.
Yewdell JW; Bennink JR
Semin Hematol; 1993 Oct; 30(4 Suppl 4):26-32; discussion 33-4. PubMed ID: 8303307
[TBL] [Abstract][Full Text] [Related]
20. EpiDOCK: a molecular docking-based tool for MHC class II binding prediction.
Atanasova M; Patronov A; Dimitrov I; Flower DR; Doytchinova I
Protein Eng Des Sel; 2013 Oct; 26(10):631-4. PubMed ID: 23661105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
